(Q28377542)

2

0 references

T Hla

3

0 references

A Hashiramoto

4

0 references

W Fukui

5

0 references

S Miyazaki

6

0 references

M Kohno

7

0 references

Y Tsubouchi

8

0 references

Y Kusaka

9

0 references

M Kondo

European Journal of Pharmacology

10

0 references

language of work or name

English

0 references

publication date

26 November 1999

0 references

published in

0 references

volume

385

0 references

issue

1

0 references

page(s)

71-9

0 references

cites work

Structure of the human cyclo-oxygenase-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Antirheumatic gold compounds and penicillamine enhance protein kinase C-mediated activation of the arachidonate-mobilizing phospholipase A2 in mouse macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor alpha mRNA in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Effects of gold compounds on the function of phagocytic cells. II. Inhibition of superoxide radical generation by tripeptide-activated polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Inhibition of human neutrophils by auranofin: chemotaxis and metabolism of arachidonate via the 5-lipoxygenase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Inhibition of protein kinase C activity by the antirheumatic drug auranofin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Meloxicam: Selective COX-2 inhibition in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Gold salts inhibit osteoclastic bone resorption in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Rheumatoid arthritis. Pathophysiology and implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Inhibition of human B cell activation by gold compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Human cyclooxygenase-2 cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Monoclonal expansion of synoviocytes in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Auranofin, gold thiomalate, and gold thioglucose inhibit protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Low-dose gold compounds inhibit fibroblast proliferation and do not affect interleukin-1 secretion by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

The oral gold compound auranofin triggers arachidonate release and cyclooxygenase metabolism in the alveolar macrophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Clinical pharmacokinetics of slow-acting antirheumatic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Aurothioglucose inhibits induced NF-kB and AP-1 activity by acting as an IL-1 functional antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Dual effects of auranofin on prostaglandin E2 production by rat peritoneal macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4

Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900707-4